{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:25:31Z","timestamp":1760984731753},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1245\/s10434-013-2880-2","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T11:34:27Z","timestamp":1359632067000},"page":"2056-2064","source":"Crossref","is-referenced-by-count":13,"title":["How Often do Level III Nodes Bear Melanoma Metastases and does it Affect Patient Outcomes?"],"prefix":"10.1245","volume":"20","author":[{"given":"Carolyn","family":"Nessim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calvin","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yarrow","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sade","family":"Shachar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"McKinnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,1]]},"reference":[{"key":"2880_CR1","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American joint committee on cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3622\u201334.","journal-title":"J Clin Oncol."},{"key":"2880_CR2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00000658-199008000-00002","volume":"212","author":"RG Bevilacqua","year":"1990","unstructured":"Bevilacqua RG, Coit DG, Rogatko A, Younes RN, Brennan MF. Axillary dissection in melanoma: prognostic variables in node-positive patients. Ann Surg. 1990; 212:125\u201331.","journal-title":"Ann Surg."},{"key":"2880_CR3","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","volume":"355","author":"DL Morton","year":"2006","unstructured":"Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307\u201317.","journal-title":"N Engl J Med."},{"key":"2880_CR4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clon.2011.04.012","volume":"23","author":"F Wright","year":"2011","unstructured":"Wright F, Spithoff K, Easson A, Murray C, Toye J, McCready D, Patrella T. Primary excision margins and sentinel lymph node biopsy in clinically node-negative melanoma of the trunk and extremities. Clin Oncol. 2011;23:572\u20138.","journal-title":"Clin Oncol."},{"key":"2880_CR5","first-page":"414","volume":"10","author":"G Plitas","year":"2012","unstructured":"Plitas G, Aryian CE. Controversies in the management of regional nodes in melanoma. J NCCN. 2012;10:414\u201321.","journal-title":"J NCCN."},{"key":"2880_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jso.20080","volume":"86","author":"LA Mack","year":"2004","unstructured":"Mack LA, McKinnon G. Controversies in the management of metastatic melanoma to regional lymphatic basins. J Surg Oncol. 2004;86:189\u201399.","journal-title":"J Surg Oncol."},{"key":"2880_CR7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1245\/s10434-008-0187-5","volume":"16","author":"C Ariyan","year":"2009","unstructured":"Ariyan C, Brady MS, G\u00f6nen M, Busam K, Coit D. Positive non-sentinel node status predicts mortality in patients with cutaneous melanoma. Ann Surg Oncol. 2009;16:186\u201390.","journal-title":"Ann Surg Oncol."},{"key":"2880_CR8","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1245\/s10434-009-0665-4","volume":"16","author":"AA Ghaferi","year":"2009","unstructured":"Ghaferi AA, Wong SL, Johnson TM, et al. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma. Ann Surg Oncol. 2009;16:2978\u201384.","journal-title":"Ann Surg Oncol."},{"key":"2880_CR9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jso.21202","volume":"99","author":"AM Easson","year":"2009","unstructured":"Easson AM, Rotstein LE, McCready DR. Lymph node assessment in melanoma. J Surg Oncol. 2009;99:176\u201385.","journal-title":"J Surg Oncol."},{"key":"2880_CR10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF02303638","volume":"5","author":"CP Karakousis","year":"1998","unstructured":"Karakousis CP. Therapeutic Node Dissections in Malignant Melanoma. Ann Surg Oncol. 1998;5:473\u201382.","journal-title":"Ann Surg Oncol."},{"key":"2880_CR11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/ejso.2001.1262","volume":"28","author":"T Meyer","year":"2002","unstructured":"Meyer T, Merkel S, G\u00f6hl J, Hohenberger W. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma. EJSO. 2002; 28:424\u201330.","journal-title":"EJSO."},{"key":"2880_CR12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejso.2006.10.032","volume":"33","author":"ACJ Akkooi van","year":"2007","unstructured":"van Akkooi ACJ, Bouwhuis MG, van Geel AN, et al. Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. EJSO. 2007;33:102\u20138.","journal-title":"EJSO."},{"key":"2880_CR13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00130404-200605000-00009","volume":"12","author":"SE Young","year":"2006","unstructured":"Young SE, Martinez SR, Faries MB, Essner R, Wanek LA, Morton DL. Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes? Cancer J. 2006;12:207\u201311.","journal-title":"Cancer J."},{"key":"2880_CR14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1245\/ASO.2003.10.001","volume":"10","author":"WR Wrightson","year":"2003","unstructured":"Wrightson WR, Wong SL, Edwards MJ, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg. 2003;10:676\u201380.","journal-title":"Ann Surg."},{"key":"2880_CR15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/bjs.4372","volume":"91","author":"T Tominaga","year":"2004","unstructured":"Tominaga T, Takashima S, Danno M. Randomized clinical trial comparing level II and level III node dissection in addition to mastectomy for breast cancer. Br J Surg. 2004;91:38\u201343.","journal-title":"Br J Surg."},{"key":"2880_CR16","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/0360-3016(86)90280-4","volume":"12","author":"D Larson","year":"1986","unstructured":"Larson D, Weinstein M, Goldberg I et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I\u2013II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys. 1986;12:1575\u201382.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2880_CR17","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/0360-3016(86)90005-2","volume":"12","author":"RD Pezner","year":"1986","unstructured":"Pezner RD, Patterson MR, Hill LR et al. Arm Lymphedema in patients treated conservatively for breast cancer: relationship to patient age and axillary node dissection technique. Int J Radiat Oncol Biol Phys. 1986;12:2079\u201383.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2880_CR18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0039-6109(02)00205-0","volume":"83","author":"R Essner","year":"2003","unstructured":"Essner R. Surgical treatment of malignant melanoma. Surg Clin North Am. 2003;83:109\u201356.","journal-title":"Surg Clin North Am."},{"key":"2880_CR19","unstructured":"NCCN (2012). Clinical practical guidelines in oncology\u2013melanoma. 2011. http:\/\/www.nccn.org\/profesion-als\/physician_gls\/PDF\/melanoma.pdf . Accessed 15 March 2012."},{"key":"2880_CR20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jso.22076","volume":"105","author":"JP Namm","year":"2012","unstructured":"Namm JP, Chang AE, Cimmino VM, Rees RS, Johnson TM, Sabel MS. Is a level III dissection necessary for a positive sentinel lymph node in melanoma? J Surg Oncol. 2012;105:225\u20138.","journal-title":"J Surg Oncol."},{"key":"2880_CR21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1200\/jco.2009.27.15_suppl.544","volume":"27","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Raval MV, Bentrem DJ, Wayne JD, Balch CM, Ko CY. National assessment of melanoma care using formally developed quality indicators. J Clin Oncol. 2009;27:544\u201357.","journal-title":"J Clin Oncol."},{"key":"2880_CR22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/(SICI)1096-9098(200003)73:3<134::AID-JSO4>3.0.CO;2-F","volume":"73","author":"S Saha","year":"2000","unstructured":"Saha S, Farrar WB, Young DC, Ferrara JJ, Burak WE. Variation in axillary node dissection influences the degree of nodal involvement in breast cancer patients. J Surg Oncol. 2000;73:134\u20137.","journal-title":"J Surg Oncol."},{"key":"2880_CR23","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1200\/JCO.2010.33.1884","volume":"29","author":"ME Valsecchi","year":"2011","unstructured":"Valsecchi ME, Silbermins D, deRosa N, Wong SL, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. J Clin Oncol. 2011;29:1479\u201387.","journal-title":"J Clin Oncol."},{"key":"2880_CR24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jso.21962","volume":"104","author":"MI Ross","year":"2011","unstructured":"Ross MI, Gershenwald JE. Evidence-based treatment of early-stage melanoma. J Surg Oncol. 2011;104:341\u201353.","journal-title":"J Surg Oncol."},{"key":"2880_CR25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jso.21465","volume":"101","author":"A Cadili","year":"2010","unstructured":"Cadili A, McKinnon G, Wright F, Hanna W, Macintosh E, Abhari Z, Dabbs K. Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma. J Surg Oncol. 2010;101:191\u20134.","journal-title":"J Surg Oncol."},{"key":"2880_CR26","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2009.27.1627","volume":"28","author":"CM Balch","year":"2010","unstructured":"Balch CM, Gershenwald JE, Soong S-J, et al. Multivariate analysis of prognostic factors among 2313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol. 2010;28:2452\u201359.","journal-title":"J Clin Oncol."},{"key":"2880_CR27","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archsurg.1989.01410090061014","volume":"124","author":"A Calabro","year":"1989","unstructured":"Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg. 1989;124:1051\u201355.","journal-title":"Arch Surg."},{"key":"2880_CR28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00000658-198103000-00023","volume":"193","author":"CM Balch","year":"1981","unstructured":"Balch CM, Soong SJ, Murad TM, et al. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg. 1981;193:377\u201388.","journal-title":"Ann Surg."},{"key":"2880_CR29","author":"K Dutton-Regester","year":"2012","unstructured":"Dutton-Regester K, Irwin D, Hunt H, et al. 2012 A high throughput panel for identifying clinically relevant mutation profiles in melanoma. Molecular Cancer Ther.. doi: 10.1158\/1535-7163.MCT-11-0676 .","journal-title":"Mol Cancer Ther"},{"key":"2880_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-8722-5-3","volume":"5","author":"B Lee","year":"2012","unstructured":"Lee B, Mukhi N, Liu D. Current management and novel agents for malignant melanoma. J Hematol Oncol. 2012;5:3-7.","journal-title":"J Hematol Oncol."},{"key":"2880_CR31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.molonc.2011.03.002","volume":"5","author":"RA Scolyer","year":"2011","unstructured":"Scolyer RA, Long GV, Thompson JF. Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Molecular Oncol. 2011;5:124\u201336.","journal-title":"Molecular Oncol."},{"key":"2880_CR32","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507\u201316.","journal-title":"N Engl J Med."},{"key":"2880_CR33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.seminoncol.2011.01.004","volume":"38","author":"TF Gajewski","year":"2011","unstructured":"Gajewski TF. Molecular Profiling of melanoma and the evolution of patient-specific therapy. Sem Oncol. 2011;38:236\u201342.","journal-title":"Sem Oncol."},{"key":"2880_CR34","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711.","journal-title":"N Engl J Med."},{"key":"2880_CR35","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","volume":"364","author":"C Robert","year":"2011","unstructured":"Robert C, Thomas L, Bondarenko I, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med. 2011;364:2517.","journal-title":"N Engl J Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-2880-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-013-2880-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-2880-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T02:22:40Z","timestamp":1644200560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-013-2880-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,1]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2880"],"URL":"https:\/\/doi.org\/10.1245\/s10434-013-2880-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,1]]}}}